SER:Serina Therapeutics Inc Snapshot | Charting | News | Options
$3.12 NYSE MKT LLC 4:15p ET
December 11 '25 		Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemi... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
     GlobeNewswire
    Full Story →

    Headline News
    Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
    4:30p ET December 10 '25 GlobeNewswire
    Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
    6:10a ET November 13 '25 GlobeNewswire
    Serina Therapeutics Provides Regulatory Update on SER-252 Program
    6:05a ET November 3 '25 GlobeNewswire
    More News →
    Day  0.64%Week  4.00%Month  23.72%More Charting →
    December 12 '25. Markets Closed.
    Last $3.12
    Day change   0.64%$0.02
    Open $3.24
    Gap at open $0.10
    Previous close $3.14
    Trading volume 13,114
    10 Day avg vol. 16,274
    Shares out. 10.7Mil
    Market cap. $33.3Mil
    Trading activity Below Avg.
    Previous data from yesterday, December 11 '25.

    Historical Price Performance
    3 month   38.46% 
    6 month   46.58% 
    1 year   30.82% 
    2 year   75.36% 

    Earnings
    Previous 12m -$1.88
    Next 12m Estimate -$2.01
    P/E ratio --
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2025 All rights reserved.